Kevin T. Strange - Feb 4, 2025 Form 4 Insider Report for Inari Medical, Inc. (NARI)

Role
Chief Financial Officer
Signature
/s/ Shannon Trevino, attorney-in-fact for Kevin T Strange
Stock symbol
NARI
Transactions as of
Feb 4, 2025
Transactions value $
$0
Form type
4
Date filed
2/6/2025, 04:45 PM
Previous filing
Jan 3, 2025
Next filing
Feb 19, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NARI Common Stock Award $0 +21.1K +45.48% $0.00 67.5K Feb 4, 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units ("RSUs") awarded to the reporting person, with a vesting commencement date of January 1, 2025 (the "Vesting Commencement Date"). 1/16th of the RSUs shall vest on each quarterly anniversary of the Vesting Commencement Date, subject to continued service through the applicable vesting date.
F2 Includes 82 shares acquired on January 31, 2025 under the Company's Employee Stock Purchase Plan.